This post was originally published on this site Imagine living your whole life with a painful disease so rare that only 25 others worldwide have what you have. And that you’re one of just six such people who’ve made it to adulthood. Neena Nizar doesn’t have to imagine. The 41-year-old English professor at Metro Community…
Conditions
Conditions
FDG PET Scan More Accurately Assesses Severity of Cognitive Decline in Alzheimer’s, Study Finds
This post was originally published on this site Compared to regular amyloid imaging, fluorodeoxyglucose positron emission tomography (FDG PET), an imaging technique that quantifies brain function by measuring glucose levels, can better assess the progression and severity of cognitive decline in people with Alzheimer’s, and also cognitive impairment, researchers have found. Their study, “18F-FDG Is…
FDA Approves Rozlytrek for Breast Cancer, Other Solid Tumors with Specific Gene Defect
This post was originally published on this site The U.S. Food and Drug Administration (FDA) has approved Rozlytrek (entrectinib) as an oral treatment for adult and adolescent patients whose breast cancer and other solid tumors have a specific genetic defect called NTRK gene fusion, have no other satisfactory therapy, is metastatic, or likely to experience severe…
Esophagogastric Cancer Patients with High DKK1 Levels Respond Better to DKN-01, Keytruda Combo, Phase 1 Trial Shows
This post was originally published on this site A combination of Leap Therapeutics‘ investigational therapy DKN-01 plus Keytruda (pembrolizumab) led to “highly encouraging” responses and survival outcomes in a population of advanced esophagogastric cancer patients with elevated levels of the Dickkopf-1 (DKK1) protein, according to preliminary results of a Phase 1 clinical trial. These results suggest…
CAR T-cell Therapy Combo Shows Promise in Treating Advanced Multiple Myeloma, Study Says
This post was originally published on this site Using a combination of CAR T-cell therapies to target different cancer molecules appears to be a feasible and promising way of treating relapsed or refractory multiple myeloma, a study reports. The findings of the study, “A combination of humanised anti-CD19 and anti-BCMA CAR T cells in patients with relapsed…
Honoring its Co-Founder’s Legacy, Newk’s Cares Kicks Off 6th Annual Ovarian Cancer Campaign
This post was originally published on this site For the sixth straight year, Newk’s Cares, the philanthropic arm of Newk’s Eatery, is raising money and awareness to battle ovarian cancer, the disease that earlier this year took the organization’s co-founder Lori Newcomb. The efforts coincide with Ovarian Cancer Awareness Month, observed each September. Chris Newcomb,…
Myriad to Seek FDA Approval of Diagnostic Test to Determine Lynparza Eligibility for mCRPC Patients
This post was originally published on this site Myriad Genetics is filing an application with the U.S. Food and Drug Administration requesting the approval of its BRACAnalysis CDx — which identifies inherited BRCA mutations — as a companion diagnostic test for selecting metastatic castration-resistant prostate cancer (mCRPC) patients eligible for Lynparza (olaparib) treatment. The announcement…
Lymphoma Research Foundation to Honor MSK’s Anas Younes at September Gala
This post was originally published on this site The Lymphoma Research Foundation will honor Anas Younes, an oncologist and lymphoma expert at Memorial Sloan Kettering (MSK) Cancer Center, with its Distinguished Leadership Award next month at the nonprofit’s annual gala. The LRF ceremony, set for Sept. 26 in New York City, coincides with National Blood Cancer Awareness Month.…
PSMA-targeted Therapies Work Best in Tumors with Mutations in DNA Repair Genes, Study Suggests
This post was originally published on this site Tumors with large numbers of prostate cancer cells with mutations in DNA repair genes are easier to target using prostate-specific membrane antigen (PSMA) therapies, and patients with these tumors are more likely to respond to this potential treatment’s use, a study found. Results from the study, “Prostate-specific Membrane…
Diet Rich in Choline Aids Memory and Lowers Risk of Dementia, Study Suggests
This post was originally published on this site A diet rich in phosphatidylcholine, a form of the choline found in foods like eggs and meat, was linked to a lower risk of dementia and better memory skills in middle-aged men in Finland, a recent study reports. These findings suggest that choline helps to support cognitive processing, and…
Finding the Motivation to Avoid the ‘Caregiving Slump’
This post was originally published on this site Life doesn’t come to a screeching halt while you care for a person who has Alzheimer’s disease. Time marches on for familial caregivers. There is a certain fluidity to life. We want to go with the flow, but it is difficult as we swim against the current.…
Oral Paclitaxel Combo Leads to Better Response Rates Than IV Therapy in MBC, Data Shows
This post was originally published on this site Treatment with a combination of oral paclitaxel and encequidar led to higher and stronger response rates compared with standard paclitaxel intravenous therapy in women with metastatic breast cancer, topline data from a Phase 3 trial shows. Paclitaxel is a widely used chemotherapy agent that interferes with the molecular…